Shared Decision Making With Pharmaceutical Care
SDMPC
Examining the Use of a Shared Decision Making Tool With Pharmaceutical Care in Type 2 Diabetes
1 other identifier
interventional
15
1 country
1
Brief Summary
A research study to enhance clinical discussion between patients and pharmacists using a shared decision making tool for type 2 diabetes or usual care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable diabetes
Started Feb 2015
Shorter than P25 for not_applicable diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2015
CompletedFirst Submitted
Initial submission to the registry
February 16, 2015
CompletedFirst Posted
Study publicly available on registry
February 26, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2015
CompletedMay 9, 2016
May 1, 2016
4 months
February 16, 2015
May 6, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Patient Involvement Questionnaire
Post-Visit up to 2 weeks
Secondary Outcomes (2)
Patient Knowledge regarding Diabetes treatments Questionnaire
post visit up to 2 weeks
Patient Medication Adherence Questionnaire
1 month post visit
Study Arms (2)
Pharmaceutical care with shared decision making
EXPERIMENTALUse of Diabetes Issue Cards Decision Aids
Usual Pharmaceutical care
ACTIVE COMPARATORUsual Care
Interventions
Eligibility Criteria
You may qualify if:
- Adults ≥ 18 years of age
- Diagnosed with type II diabetes by ICD-9 code for more than one year
- HbA1c of 7%-9.5% within past 6 months
- Prescribed three or less anti-hyperglycemic medications as indicated by the medication list within the medical record
You may not qualify if:
- Prescribed insulin
- Pregnancy
- Appointment with provider within a month
- Appointment with provider within the last month
- Followed by endocrinology
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (1)
Mayo Clinic Kasson
Kasson, Minnesota, 55944, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor of Pharmacy
Study Record Dates
First Submitted
February 16, 2015
First Posted
February 26, 2015
Study Start
February 1, 2015
Primary Completion
June 1, 2015
Study Completion
June 1, 2015
Last Updated
May 9, 2016
Record last verified: 2016-05